Table 2.
1H-NMR targeted metabolomics data for choline treatment (13).
Metabolite a | WT | HET | HET+Cho | p-value |
---|---|---|---|---|
Ketoglutarate | 0.041 ± 0.01 | 0.046 ± 0.004 | 0.039 ± 0.01 | 0.3968 |
Hydroxybutyrate | 0.229 ± 0.035 | 0.210 ± 0.03 | 0.106 ± 0.02*# | 0.0377 |
Acetate | 0.082 ± 0.015 | 0.089 ± 0.01 | 0.024 ± 0.002*# | 0.0110 |
Methylmalonate | 0.031 ± 0.003 | 0.037 ± 0.005 | 0.031 ± 0.004 | 0.4810 |
Betaine | 0.048 ± 0.004 | 0.053 ± 0.005 | 0.036 ± 0.004# | 0.0397 |
Choline | 0.018 ± 0.001 | 0.017 ± 0.002 | 0.015 ± 0.0004* | 0.0430 |
Creatine | 0.143 ± 0.01 | 0.141 ± 0.01 | 0.102 ± 0.01*# | 0.0083 |
DMG | 0.009 ± 0.001 | 0.006 ± 0.0005* | 0.010 ± 0.0003*# | 0.0328,0.0482 |
Sarcosine | 0.010 ± 0.002 | 0.009 ± 0.001 | 0.003 ± 0.0004*# | 0.0002 |
Taurine | 0.517 ± 0.04 | 0.614 ± 0.05 | 0.219 ± 0.06*# | 0.0105 |
Glucose | 10.08 ± 0.68 | 12.96 ± 1.02* | 12.24 ± 0.90* | 0.0467,0.0493 |
Lactate | 6.40 ± 0.57 | 7.30 ± 1.04 | 6.99 ± 0.53 | 0.8313 |
Glutamine | 0.474 ± 0.02 | 0.614 ± 0.02* | 0.575 ± 0.03* | 0.0217,0.0326 |
Glycerol | 1.19 ± 0.21 | 0.72 ± 0.06 | 2.26 ± 0.21*# | < 0.0001 |
Succinate | 0.161 ± 0.02 | 0.257 ± 0.07 | 0.403 ± 0.06* | 0.0181 |
Glycine | 0.254 ± 0.01 | 0.276 ± 0.02 | 0.282 ± 0.05* | 0.0455 |
Leucine | 0.142 ± 0.015 | 0.147 ± 0.02 | 0.110 ± 0.005 | 0.1779 |
Isoleucine | 0.108 ± 0.01 | 0.101 ± 0.015 | 0.075 ± 0.005 | 0.2290 |
Histidine | 0.062 ± 0.003 | 0.063 ± 0.005 | 0.061 ± 0.004 | 0.7811 |
Lysine | 0.289 ± 0.015 | 0.241 ± 0.02* | 0.190 ± 0.01*# | 0.0380,0.0248 |
Serine | 0.178 ± 0.015 | 0.165 ± 0.02 | 0.180 ± 0.02 | 0.6545 |
Phenylalanine | 0.073 ± 0.009 | 0.083 ± 0.007 | 0.063 ± 0.006 | 0.3728 |
Threonine | 0.173 ± 0.01 | 0.185 ± 0.02 | 0.124 ± 0.01* | 0.0423 |
Tyrosine | 0.101 ± 0.01 | 0.100 ± 0.01 | 0.080 ± 0.015 | 0.2768 |
Alanine | 0.456 ± 0.04 | 0.521 ± 0.06 | 0.444 ± 0.04 | 0.3881 |
Valine | 0.242 ± 0.03 | 0.232 ± 0.03 | 0.258 ± 0.02 | 0.3118 |
mM ± S.E.M; Shown are P-values for one-way ANOVA. Significant differences are in bold and compared relative to(*)WT and(#)HET groups.